Both healthcare stocks have impeccable dividend track records and bright futures still ahead. Broader equities have been volatile this year, but that's par for the course. The fact that the stock ...

The stock's fall snapped a two-day winning streak.

CALIFORNIA, CA, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- The Type 2 Diabetes market is undergoing significant ...

DexCom has been a great trade. While the S&P 500 was flat, the stock price has climbed by 15.6% to $87 per share. This was ...

In earnings calls, diabetes tech companies had less to say about tariffs and focused more on future growth.

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A strong ...

25 analysts are following DexCom and have set target prices ranging from $82.0 to $110.0 per share. On average, they have ...

Dexcom Inc. defeated investor allegations the glucose monitor maker exaggerated its ability to tap into the market of ...

DexCom Inc. closed 34.58% short of its 52-week high of $132.26, which the company reached on May 17th.

In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against other best medical device stocks to buy now. On April 16, CNBC reported that Trump’s tariffs are ...

DexCom (NASDAQ:DXCM) stock experienced a significant 16% surge on Friday following its Q1 earnings release and a share buyback announcement. The company’s first-quarter sales reached $1.04 ...